CPBIO (03839) Announces First Three Quarters Results: Profit Attributable to Shareholders US$12.147 Million, Down 48.39% Year-on-Year
CPBIO (03839) Announces First Three Quarters Results: Profit Attributable to Shareholders US$12.147 Million, Down 48.39% Year-on-Year
CPBIO (03839) released its results for the first three quarters ended 2026. The Group recorded revenue of US$332 million, down 22.98% year-on-year; profit attributable to shareholders was US$12.147 million, down 48.39% year-on-year.
CPBIO (03839) announced its results for the first three quarters ended 2026. The group recorded revenue of US$332 million, down 22.98% year-on-year; profit attributable to shareholders was US$12.147 million, down 48.39% year-on-year.
Related Articles
TIAN CHENG HLDG (02110) proposes to issue rights shares on a "1-for-3" basis at a discount of approximately 29.31%.
US Stock Market Move | NVIDIA Corporation (NVDA.US) rose nearly 4% in pre-market trading; Goldman Sachs Group, Inc. said its third-quarter results are expected to beat expectations.
SEM HLDGS (09929) grants a total of 4.61 million restricted share units
TIAN CHENG HLDG (02110) proposes to issue rights shares on a "1-for-3" basis at a discount of approximately 29.31%.
US Stock Market Move | NVIDIA Corporation (NVDA.US) rose nearly 4% in pre-market trading; Goldman Sachs Group, Inc. said its third-quarter results are expected to beat expectations.
SEM HLDGS (09929) grants a total of 4.61 million restricted share units
